Tilray Brands, Inc. (TLRY)
5.32
-0.18
(-3.27%)
USD |
NASDAQ |
May 15, 16:00
5.30
-0.02
(-0.38%)
After-Hours: 20:00
Tilray Brands EPS Diluted (Quarterly) : -0.2358 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CannaPharmaRx, Inc. | -0.0115 |
| Lexaria Bioscience Corp. | -0.0593 |
| InMed Pharmaceuticals, Inc. | -0.7327 |
| Target Group, Inc. (Canada) | -0.0009 |
| NervGen Pharma Corp. | -0.0153 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.23M |
| Revenue (Quarterly) | 206.73M |
| Total Expenses (Quarterly) | 233.30M |
| Enterprise Value | 637.62M |
| Gross Profit Margin (Quarterly) | 24.11% |
| Profit Margin (Quarterly) | -12.21% |
| Earnings Yield | -256.8% |
| Normalized Earnings Yield | -64.37 |